The Not so Rare “Rare” Diseases Current and future challenges in clinical research of rare diseases What are rare diseases? As implied in its name, rare diseases affect small percentages of patients. However, when factoring in the multitude of rare diseases, the overall number of people affected by them is a staggering 475 million worldwide. According to the National Institutes of Read more
Türkiye – a Hidden Gem in Clinical Research Firstly, it is official – Turkey is now Türkiye. This change took place past summer when the United Nations officially recognized the new name.  With a population of over 85 million, a well developed universal healthcare system, a relatively low per capita number of clinical trials, a large pool of treatment-naive patients, Türkiye is a Read more
News Digest on Biotech & Pharma Industry #9 | Cromos Pharma
Clinical Research Focus. 9th Edition Cromos Pharma Strengthens Its Operations in Türkiye, Kazakhstan and Serbia Cromos Pharma, a US-based international CRO with a strong presence in Central and Eastern Europe, is strengthening its presence in Türkiye, Kazakhstan and Serbia by establishing local legal entities, opening full scale offices, and increasing the local staff presence. The company plans to use its Read more
Clinical Trials in Kazakhstan – Country Profile for 2022 There are many benefits to conducting clinical research in Kazakhstan, its strategic location being one of them. Kazakhstan is a transcontinental country located between Europe and Central Asia; it’s health demographics draw influence from both continents. This is one reason why more and more healthcare organizations are becoming interested in this nation as a venue Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us